BRD2 and neoplasm: The phosphoproteomic analysis identified 914 tyrosine phosphosites in total, with 602 tyrosine phosphosites from 477 phosphoproteins in 96 tumor samples, and 495 phosphosites from 407 phosphoproteins in 90 NAT samples, respectively (Supplementary Fig. S2k).